
### [MONDO:0000184](http://purl.obolibrary.org/obo/MONDO_0000184)
**Label:** congenital vitamin K-dependent coagulation factors combined deficiency

**Subclasses:** [MONDO:0011837](http://purl.obolibrary.org/obo/MONDO_0011837) (vitamin K-dependent clotting factors, combined deficiency of, type 2), [MONDO:0010187](http://purl.obolibrary.org/obo/MONDO_0010187) (vitamin K-dependent clotting factors, combined deficiency of, type 1), 

**Corr. equiv. classes:** [OMIM:277450](http://purl.obolibrary.org/obo/OMIM_277450), [Orphanet:98434](http://www.orpha.net/ORDO/Orphanet_98434), [OMIM:607473](http://purl.obolibrary.org/obo/OMIM_607473), 

**Class expressions from DL-Learner:**

- [HP:0011858](http://purl.obolibrary.org/obo/HP_0011858) (Reduced factor IX activity) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010990](http://purl.obolibrary.org/obo/HP_0010990) (Abnormality of the common coagulation pathway) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010988](http://purl.obolibrary.org/obo/HP_0010988) (Abnormality of the extrinsic pathway) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0008321](http://purl.obolibrary.org/obo/HP_0008321) (Reduced factor X activity) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0008169](http://purl.obolibrary.org/obo/HP_0008169) (Reduced factor VII activity) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0008169](http://purl.obolibrary.org/obo/HP_0008169) (Reduced factor VII activity) and [HP:0012200](http://purl.obolibrary.org/obo/HP_0012200) (Abnormality of prothrombin) 66.67%
- [HP:0008169](http://purl.obolibrary.org/obo/HP_0008169) (Reduced factor VII activity) and [HP:0011858](http://purl.obolibrary.org/obo/HP_0011858) (Reduced factor IX activity) 66.67%
- [HP:0008169](http://purl.obolibrary.org/obo/HP_0008169) (Reduced factor VII activity) and [HP:0010990](http://purl.obolibrary.org/obo/HP_0010990) (Abnormality of the common coagulation pathway) 66.67%
- [HP:0008169](http://purl.obolibrary.org/obo/HP_0008169) (Reduced factor VII activity) and [HP:0008321](http://purl.obolibrary.org/obo/HP_0008321) (Reduced factor X activity) 66.67%
- [HP:0010990](http://purl.obolibrary.org/obo/HP_0010990) (Abnormality of the common coagulation pathway) and [HP:0011858](http://purl.obolibrary.org/obo/HP_0011858) (Reduced factor IX activity) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0010990](http://purl.obolibrary.org/obo/HP_0010990) (Abnormality of the common coagulation pathway) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010988](http://purl.obolibrary.org/obo/HP_0010988) (Abnormality of the extrinsic pathway) and [HP:0011858](http://purl.obolibrary.org/obo/HP_0011858) (Reduced factor IX activity) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010988](http://purl.obolibrary.org/obo/HP_0010988) (Abnormality of the extrinsic pathway) and [HP:0010990](http://purl.obolibrary.org/obo/HP_0010990) (Abnormality of the common coagulation pathway) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%
- [HP:0010988](http://purl.obolibrary.org/obo/HP_0010988) (Abnormality of the extrinsic pathway) and [HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway) and [HP:0012201](http://purl.obolibrary.org/obo/HP_0012201) (Reduced prothrombin activity) 66.67%


